Lesia V. Rasputina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lesia V. Rasputina has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Daria V. Didenko
National Pirogov Memorial Medical University, Vinnytsia, Ukraine
5 shared publications - Andrii V. Solomonchuk
Vinnytsia Regional Clinical Treatment Diagnostic Center of Cardiovascular Pathology, Vinnytsia, Ukraine
4 shared publications D. V. Didenko
Вінницький національний медичний університет імені М. І. Пирогова
3 shared publicationsDaria Didenko
Chair of Propadeutics of Internal Medicine, Vinnytsia National Pirogov Memorial Medical University
3 shared publications- Mariia Ovcharuk
Vinnytsia National Pirogov Medical University
3 shared publications Nataliya Cherepii
Chair of Propadeutics of Internal Medicine, Vinnytsia National Pirogov Memorial Medical University
3 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (Додаток 2 )
Серцево-судинні захворювання та хронічна хвороба нирок. Клінічний експертний консенсус Всеукраїнської асоціації кардіологів України та Української асоціації нефрологів і фахівців з трансплантації нирки
Мета створення клінічного експертного консенсусу – підвищити інформованість кардіологів щодо сповільнення темпів прогресування cерцево-судинних захворювань та хронічної хвороби нирок шляхом впровадження алгоритмів менеджменту таких хворих відповідно до міжнародних і національних настанов, клінічних протоколів та власного досвіду експертів.
- 23 October 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (Додаток 2 )
Open AccessСерцево-судинні захворювання та хронічна хвороба нирок. Клінічний експертний консенсус Всеукраїнської асоціації кардіологів України та Української асоціації нефрологів і фахівців з трансплантації нирки
Мета створення клінічного експертного консенсусу – підвищити інформованість кардіологів щодо сповільнення темпів прогресування cерцево-судинних захворювань та хронічної хвороби нирок шляхом впровадження алгоритмів менеджменту таких хворих відповідно до міжнародних і національних настанов, клінічних протоколів та власного досвіду експертів.
- Open Access
- 30 September 2026
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 34 (3) , 24-30
Clinical, Laboratory and Echocardiographic Features in Severe Acute Myocardial Infarction Complicated by Acute Heart Failure
Aim. To determine the clinical, laboratory, and instrumental characteristics of acute myocardial infarction (AMI) complicated by severe acute heart failure (AHF).Materials and methods. This single-center prospective observational cohort study included 137 patients with AMI complicated by AHF who underwent percutaneous coronary intervention (PCI). According to the Killip classification, patients were divided into three groups: class II (n=46), class III (n=43), and cardiogenic shock (class IV, n=48). Laboratory tests included complete blood count, creatinine, NT-proBNP, troponin I, CK-MB, D-dimer, and C-reactive protein. All patients underwent echocardiography and coronary angiography. Statistical analysis included parametric and nonparametric tests, correlation analysis, and multivariate logistic regression.Results. Increasing AHF severity was associated with lower hemoglobin levels (p<0.001) and higher levels of NT-proBNP (p<0.001), C-reactive protein (p<0.001), creatinine (p<0.05), and CK-MB (p<0.05). Progressive reduction in left ventricular ejection fraction (LVEF) was observed with increasing AHF severity (52.4±0.8% in Killip class II vs. 35.6±1.1% in Killip class IV; p<0.0001), accompanied by increased left ventricular volumes (p<0.001) and signs of adverse myocardial remodeling. Patients with severe AHF more frequently had multivessel coronary artery disease and less favorable restoration of coronary blood flow after PCI. NT-proBNP levels correlated with left ventricular end-diastolic volume both at admission and discharge, suggesting its potential role as a marker of left ventricular remodeling. Multivariate analysis identified elevated NT-proBNP (OR=1.42; p<0.001), LVEF <40% (OR=2.86; p<0.001), multivessel coronary artery disease (OR=2.11; p10 mg/L (OR=1.78; p<0.05), and glomerular filtration rate <60 mL/min (OR=1.95; p<0.01) as independent predictors of cardiogenic shock. These findings allowed identification of a “high-risk phenotype” of severe AHF characterized by neurohumoral activation, elevated LV filling pressure reflected by increased E/e′, systemic inflammation, LV systolic dysfunction, multivessel coronary artery disease, and renal dysfunction.Conclusions. Severe AHF in patients with AMI is characterized by pronounced laboratory abnormalities and structural and functional myocardial changes, highlighting the importance of comprehensive assessment for early risk stratification and optimization of treatment strategies.
- 30 September 2026
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 34 (3) , 24-30
Open AccessClinical, Laboratory and Echocardiographic Features in Severe Acute Myocardial Infarction Complicated by Acute Heart Failure
Aim. To determine the clinical, laboratory, and instrumental characteristics of acute myocardial infarction (AMI) complicated by severe acute heart failure (AHF).Materials and methods. This single-center prospective observational cohort study included 137 patients with AMI complicated by AHF who underwent percutaneous coronary intervention (PCI). According to the Killip classification, patients were divided into three groups: class II (n=46), class III (n=43), and cardiogenic shock (class IV, n=48). Laboratory tests included complete blood count, creatinine, NT-proBNP, troponin I, CK-MB, D-dimer, and C-reactive protein. All patients underwent echocardiography and coronary angiography. Statistical analysis included parametric and nonparametric tests, correlation analysis, and multivariate logistic regression.Results. Increasing AHF severity was associated with lower hemoglobin levels (p<0.001) and higher levels of NT-proBNP (p<0.001), C-reactive protein (p<0.001), creatinine (p<0.05), and CK-MB (p<0.05). Progressive reduction in left ventricular ejection fraction (LVEF) was observed with increasing AHF severity (52.4±0.8% in Killip class II vs. 35.6±1.1% in Killip class IV; p<0.0001), accompanied by increased left ventricular volumes (p<0.001) and signs of adverse myocardial remodeling. Patients with severe AHF more frequently had multivessel coronary artery disease and less favorable restoration of coronary blood flow after PCI. NT-proBNP levels correlated with left ventricular end-diastolic volume both at admission and discharge, suggesting its potential role as a marker of left ventricular remodeling. Multivariate analysis identified elevated NT-proBNP (OR=1.42; p<0.001), LVEF <40% (OR=2.86; p<0.001), multivessel coronary artery disease (OR=2.11; p10 mg/L (OR=1.78; p<0.05), and glomerular filtration rate <60 mL/min (OR=1.95; p<0.01) as independent predictors of cardiogenic shock. These findings allowed identification of a “high-risk phenotype” of severe AHF characterized by neurohumoral activation, elevated LV filling pressure reflected by increased E/e′, systemic inflammation, LV systolic dysfunction, multivessel coronary artery disease, and renal dysfunction.Conclusions. Severe AHF in patients with AMI is characterized by pronounced laboratory abnormalities and structural and functional myocardial changes, highlighting the importance of comprehensive assessment for early risk stratification and optimization of treatment strategies.
- Open Access
- 30 June 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (3) , 26-38
Особливості клінічного стану та результатів інструментально-лабораторного обстеження пацієнтів з хронічною серцевою недостатністю різних фенотипів в умовах реальної клінічної практики
Мета роботи – визначити відмінності факторів ризику, супутніх захворювань, лабораторних маркерів, ехокардіографічних параметрів та показників добового моніторування ЕКГ в пацієнтів із хронічною серцевою недостатністю (СН) залежно від систолічної функції лівого шлуночка (ЛШ).Матеріали і методи. У дослідження залучено 103 пацієнти із СН віком у середньому (66,7±0,9) року, серед них було 85 (82,5 %) чоловіків та 18 (17,5 %) жінок. Усі пацієнти були розподілені на 3 групи залежно від показника систолічної функції ЛШ: в групі зниженої фракції викиду ЛШ (СНзнФВ) було 25 (24,3 %) осіб, в групі помірно зниженої фракції викиду ЛШ (СНпзнФВ) – 48 (46,6 %) пацієнтів; в групі збереженої фракції викиду ЛШ (СНзбФВ) – 30 (29,1 %) осіб. Пацієнтам проведено збір анамнезу, загальноклінічне обстеження, ЕКГ, ехокардіографію (ЕхоКГ), добове моніторування ЕКГ (ДМ ЕКГ), визначено лабораторні показники – загальний аналіз крові, рівні глікемії, глікозильованого гемоглобіну, ліпідів, креатиніну, калію сироватки, тиреотропного гормону, N-кінцевого фрагмента мозкового натрійуретичного пропептиду, виконано статистичну обробку даних.Результати. Виявлено, що пацієнти із СНзнФВ частіше мають в анамнезі ішемічну хворобу серця (ІХС) (76 %), цукровий діабет (ЦД) (24 %) та постійну форму фібриляції передсердь (ФП) (36 %) порівняно з пацієнтами із СНзбФВ – 43,3; 6,7 та 6,75 % відповідно (р<0,05). Водночас пацієнти з різними фенотипами СН не відрізняються за частотою виявлення гіпертонічної хвороби (ГХ) 3-го ступеня, хронічного обструктивного захворювання легень (ХОЗЛ), пароксизмальної форми ФП та стабільної стенокардії ІІІ функціонального класу. В осіб групи СНзнФВ частіше спостерігали стеноз стовбура лівої або правої коронарної артерії (22,7 %) та ураження кількох коронарних артерій (63,6 %), на відміну від пацієнтів із СНзбФВ (р=0,004 та р=0,03 відповідно). В групі СНзбФВ частіше відзначали гемодинамічно значуще ураження передньої міжшлуночкової гілки лівої коронарної артерії – 47 % (р=0,05). В обстежених із СНзнФВ виявлено більш значущі порушення функції нирок, а саме вищий рівень калію сироватки – (4,6±0,1) ммоль/л (проти (3,93±0,1) в групі СНпзнФВ, р=0,007) та нижчий показник розрахованої швидкості клубочкової фільтрації (52,7±2,7) мл/хв (проти (72,4±3,6) мл/хв в групі СНзбФВ, р=0,02). За даними ДМ ЕКГ більша схильність до синусової тахікардії виявлена в групі СНзнФВ – мінімальна частота серцевих скорочень (ЧСС) в активний час становила 69,4±2,1 за 1 хв проти 46,2±2,0 в групі СНпзнФВ (р=0,0001) та 55,1±2,5 у групі СНзбФВ (р=0,007). Мінімальна ЧСС уночі була найвищою в осіб із СНзнФВ – 69,6±2,7 за 1 хв; в групі СНпзнФВ вона становила 49,7±3,1 за 1 хв (р=0,007); у групі СНзбФВ – 52,5±2,7 за 1 хв (р=0,0009).Висновки. Виявлено, що пацієнти усіх фенотипів СН, котрі лікуються амбулаторно, отримують недостатню базисну терапію, зокрема інгібітори натрійзалежного котранспортера глюкози 2-го типу отримують лише 15,5 % пацієнтів, а терапію петльовими діуретиками – загалом 66,6 % без статистично значущої відмінності між групами, що свідчить про частіше використання симптоматичної, а не патогенетичної і прогнозомодифікувальної терапії. Ця проблема потребує глибокого аналізу причин і виявлення факторів, які перешкоджають повноцінному впровадженню сучасних стратегій лікування.
- 30 June 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (3) , 26-38
Open AccessОсобливості клінічного стану та результатів інструментально-лабораторного обстеження пацієнтів з хронічною серцевою недостатністю різних фенотипів в умовах реальної клінічної практики
Мета роботи – визначити відмінності факторів ризику, супутніх захворювань, лабораторних маркерів, ехокардіографічних параметрів та показників добового моніторування ЕКГ в пацієнтів із хронічною серцевою недостатністю (СН) залежно від систолічної функції лівого шлуночка (ЛШ).Матеріали і методи. У дослідження залучено 103 пацієнти із СН віком у середньому (66,7±0,9) року, серед них було 85 (82,5 %) чоловіків та 18 (17,5 %) жінок. Усі пацієнти були розподілені на 3 групи залежно від показника систолічної функції ЛШ: в групі зниженої фракції викиду ЛШ (СНзнФВ) було 25 (24,3 %) осіб, в групі помірно зниженої фракції викиду ЛШ (СНпзнФВ) – 48 (46,6 %) пацієнтів; в групі збереженої фракції викиду ЛШ (СНзбФВ) – 30 (29,1 %) осіб. Пацієнтам проведено збір анамнезу, загальноклінічне обстеження, ЕКГ, ехокардіографію (ЕхоКГ), добове моніторування ЕКГ (ДМ ЕКГ), визначено лабораторні показники – загальний аналіз крові, рівні глікемії, глікозильованого гемоглобіну, ліпідів, креатиніну, калію сироватки, тиреотропного гормону, N-кінцевого фрагмента мозкового натрійуретичного пропептиду, виконано статистичну обробку даних.Результати. Виявлено, що пацієнти із СНзнФВ частіше мають в анамнезі ішемічну хворобу серця (ІХС) (76 %), цукровий діабет (ЦД) (24 %) та постійну форму фібриляції передсердь (ФП) (36 %) порівняно з пацієнтами із СНзбФВ – 43,3; 6,7 та 6,75 % відповідно (р<0,05). Водночас пацієнти з різними фенотипами СН не відрізняються за частотою виявлення гіпертонічної хвороби (ГХ) 3-го ступеня, хронічного обструктивного захворювання легень (ХОЗЛ), пароксизмальної форми ФП та стабільної стенокардії ІІІ функціонального класу. В осіб групи СНзнФВ частіше спостерігали стеноз стовбура лівої або правої коронарної артерії (22,7 %) та ураження кількох коронарних артерій (63,6 %), на відміну від пацієнтів із СНзбФВ (р=0,004 та р=0,03 відповідно). В групі СНзбФВ частіше відзначали гемодинамічно значуще ураження передньої міжшлуночкової гілки лівої коронарної артерії – 47 % (р=0,05). В обстежених із СНзнФВ виявлено більш значущі порушення функції нирок, а саме вищий рівень калію сироватки – (4,6±0,1) ммоль/л (проти (3,93±0,1) в групі СНпзнФВ, р=0,007) та нижчий показник розрахованої швидкості клубочкової фільтрації (52,7±2,7) мл/хв (проти (72,4±3,6) мл/хв в групі СНзбФВ, р=0,02). За даними ДМ ЕКГ більша схильність до синусової тахікардії виявлена в групі СНзнФВ – мінімальна частота серцевих скорочень (ЧСС) в активний час становила 69,4±2,1 за 1 хв проти 46,2±2,0 в групі СНпзнФВ (р=0,0001) та 55,1±2,5 у групі СНзбФВ (р=0,007). Мінімальна ЧСС уночі була найвищою в осіб із СНзнФВ – 69,6±2,7 за 1 хв; в групі СНпзнФВ вона становила 49,7±3,1 за 1 хв (р=0,007); у групі СНзбФВ – 52,5±2,7 за 1 хв (р=0,0009).Висновки. Виявлено, що пацієнти усіх фенотипів СН, котрі лікуються амбулаторно, отримують недостатню базисну терапію, зокрема інгібітори натрійзалежного котранспортера глюкози 2-го типу отримують лише 15,5 % пацієнтів, а терапію петльовими діуретиками – загалом 66,6 % без статистично значущої відмінності між групами, що свідчить про частіше використання симптоматичної, а не патогенетичної і прогнозомодифікувальної терапії. Ця проблема потребує глибокого аналізу причин і виявлення факторів, які перешкоджають повноцінному впровадженню сучасних стратегій лікування.
- Open Access
- 25 March 2025
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (1) , 103-111
Impact of Acute Complications on The Course and Outcome of Severe COVID-19: a Clinical Analysis and Determination of Mortality Predictors
Aim. To establish the features of the clinical picture, the structure of acute complications and predictors of mortality in patients with a severe course of COVID-19. Materials and methods. 221 patients who were in the intensive care unit (ICU) of City Clinical Hospital No. 1 in Vinnytsia, Ukraine were examined in the period 2020-2023. Among them, 133 (60.2%) patients survived and 88 (39.8%) of patients died as a result of a severe course of COVID-19 (p = 0.02). Results. The mortality rate of patients with a severe course of COVID-19 was 39.8%. Among patients classified as categories 6 and 7 by the WHO, the highest mortality was observed, (p<0.001). In the group of deceased patients, there were significantly more patients with hypertension (73 (83.0%) vs. 90 (67.7%), p=0.008), coronary heart disease (CHD) (83 (94.3%) vs. 91 (68.4%)), p = 0.0001), a combination of CAD and hypertension (72 (81.8%) vs. 79 (59.4%), p < 0.001). In addition, acute/chronic kidney diseases (18 (20.5%) vs. 13 (9.8%), p = 0.022) and cancer were more common (12 (13.6%) vs. 8 (6.0%)), p = 0.046). Among the acute complications that occurred during the stay of patients in the ICU, the deceased patients experienced significantly higher rates of the following conditions: stroke (10 (11.4%) vs. 3 (2.3%), p = 0.006), acute heart failure (9 (10.2%) vs. 4 (3.0%), p = 0.038), pulmonary embolism (9 (10.2%) vs. 3 (2.3%), p = 0.014), infectious toxic shock (10 (11.4%) vs. 1 (0.8%), p = 0.001), acute respiratory distress syndrome (78 (88.6%) vs. 6 (4.5%), p < 0.0001), endstage of renal failure (62 (80.5%) vs. 82 (62.1%), p = 0.006). Additionally, among rhythm disturbances, atrial fibrillation was more prevalent in deceased patients and was associated with a lower survival rate (31 (35.2%) vs. 19 (14.3%), p = 0.0001). Conclusions. The study demonstrated that clinical factors associated with mortality in patients with a severe course of COVID-19 include patient age and с omorbidity such as hypertension, CAD, heart failure and rhythm disorders. Tachyarrhythmias and bradyarrhythmias were more often observed in deceased patients, in particular, they had more frequent AF, which emphasizes its role as a predictor of poor prognosis in patients with COVID-19.
- 25 March 2025
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (1) , 103-111
Open AccessImpact of Acute Complications on The Course and Outcome of Severe COVID-19: a Clinical Analysis and Determination of Mortality Predictors
Aim. To establish the features of the clinical picture, the structure of acute complications and predictors of mortality in patients with a severe course of COVID-19. Materials and methods. 221 patients who were in the intensive care unit (ICU) of City Clinical Hospital No. 1 in Vinnytsia, Ukraine were examined in the period 2020-2023. Among them, 133 (60.2%) patients survived and 88 (39.8%) of patients died as a result of a severe course of COVID-19 (p = 0.02). Results. The mortality rate of patients with a severe course of COVID-19 was 39.8%. Among patients classified as categories 6 and 7 by the WHO, the highest mortality was observed, (p<0.001). In the group of deceased patients, there were significantly more patients with hypertension (73 (83.0%) vs. 90 (67.7%), p=0.008), coronary heart disease (CHD) (83 (94.3%) vs. 91 (68.4%)), p = 0.0001), a combination of CAD and hypertension (72 (81.8%) vs. 79 (59.4%), p < 0.001). In addition, acute/chronic kidney diseases (18 (20.5%) vs. 13 (9.8%), p = 0.022) and cancer were more common (12 (13.6%) vs. 8 (6.0%)), p = 0.046). Among the acute complications that occurred during the stay of patients in the ICU, the deceased patients experienced significantly higher rates of the following conditions: stroke (10 (11.4%) vs. 3 (2.3%), p = 0.006), acute heart failure (9 (10.2%) vs. 4 (3.0%), p = 0.038), pulmonary embolism (9 (10.2%) vs. 3 (2.3%), p = 0.014), infectious toxic shock (10 (11.4%) vs. 1 (0.8%), p = 0.001), acute respiratory distress syndrome (78 (88.6%) vs. 6 (4.5%), p < 0.0001), endstage of renal failure (62 (80.5%) vs. 82 (62.1%), p = 0.006). Additionally, among rhythm disturbances, atrial fibrillation was more prevalent in deceased patients and was associated with a lower survival rate (31 (35.2%) vs. 19 (14.3%), p = 0.0001). Conclusions. The study demonstrated that clinical factors associated with mortality in patients with a severe course of COVID-19 include patient age and с omorbidity such as hypertension, CAD, heart failure and rhythm disorders. Tachyarrhythmias and bradyarrhythmias were more often observed in deceased patients, in particular, they had more frequent AF, which emphasizes its role as a predictor of poor prognosis in patients with COVID-19.
- Open Access
- 4 October 2024
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 26 (5) , 434-440
Prosthetic valve thrombosis in a patient secondary to COVID-19: a case report
A well-known and dangerous complication of COVID-19 infection is the development of hypercoagulation, which leads to thrombosis of various localization. Therefore, the problem of anticoagulant therapy was widely discussed during the first months of the pandemic and continues to be relevant. At the same time, concomitant cardiac pathology is associated with a more severe course of COVID-19 and higher risks of complications and mortality. Therefore, patients who underwent cardiac surgery require special attention. Individuals with prosthetic metal heart valves must constantly receive anticoagulant therapy, however, the literature describes cases of intracardiac thrombotic complications despite anticoagulation during COVID-19 infection. Currently, there are no randomized studies on this issue, and only individual clinical cases provide this information. The aim of the work was to describe a clinical case of thrombosis at the left ventricular apex during COVID-19 infection in a patient with a prosthetic aortic valve who received adequate warfarin therapy and to compare the tactics of patient management and therapeutic outcomes with other clinical cases. Materials and methods. The patient was followed-up after aortic valve replacement for 2 years. During the visits, a general clinical examination, laboratory examinations – clinical blood test, blood glucose, urea, creatinine, bilirubin, INR, NT-proBNP, echocardiography were performed. Results. The patient with a congenital heart defect, a condition after aortic valve replacement, mitral and tricuspid valve annuloplasty (15.03.2022) due to bicuspid aortic valve, combined aortic defect with predominance of stage III-IV regurgitation; stage III secondary arterial hypertension; chronic heart failure IIA, functional class III, stage C, reduced systolic left ventricular function; a two-chamber pacemaker due to complete AV blockade; paroxysmal atrial flutter presented to a cardiologist with worsening shortness of breath and weakness one month after a moderate COVID-19 infection. The patient received bisoprolol 5 mg, amiodarone 200 mg, spironolactone 50 mg, perindopril 8 mg, warfarin 5 mg, INR was carefully controlled, at presentation – 3.7. Echocardiography revealed a left ventricular apex thrombus, a decrease in left ventricular ejection fraction (LVEF) from 46 % to 38 %. Aspirin 75 mg/day, torasemide 10 mg/day, dapagliflozin 10 mg/day, and metabolic therapy were added to the treatment. After 1 month, the patient’s condition improved, no thrombus was detected in the left ventricular cavity, LVEF increased to 46 %. Conclusions. This case demonstrates the problem of careful cardiovascular system state monitoring in patients with prosthetic valves during and after COVID-19, since symptoms of heart cavity or valve thrombosis, worsening heart failure can be mistakenly considered as signs of a viral infection or respiratory failure.
- 4 October 2024
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 26 (5) , 434-440
Open AccessProsthetic valve thrombosis in a patient secondary to COVID-19: a case report
A well-known and dangerous complication of COVID-19 infection is the development of hypercoagulation, which leads to thrombosis of various localization. Therefore, the problem of anticoagulant therapy was widely discussed during the first months of the pandemic and continues to be relevant. At the same time, concomitant cardiac pathology is associated with a more severe course of COVID-19 and higher risks of complications and mortality. Therefore, patients who underwent cardiac surgery require special attention. Individuals with prosthetic metal heart valves must constantly receive anticoagulant therapy, however, the literature describes cases of intracardiac thrombotic complications despite anticoagulation during COVID-19 infection. Currently, there are no randomized studies on this issue, and only individual clinical cases provide this information. The aim of the work was to describe a clinical case of thrombosis at the left ventricular apex during COVID-19 infection in a patient with a prosthetic aortic valve who received adequate warfarin therapy and to compare the tactics of patient management and therapeutic outcomes with other clinical cases. Materials and methods. The patient was followed-up after aortic valve replacement for 2 years. During the visits, a general clinical examination, laboratory examinations – clinical blood test, blood glucose, urea, creatinine, bilirubin, INR, NT-proBNP, echocardiography were performed. Results. The patient with a congenital heart defect, a condition after aortic valve replacement, mitral and tricuspid valve annuloplasty (15.03.2022) due to bicuspid aortic valve, combined aortic defect with predominance of stage III-IV regurgitation; stage III secondary arterial hypertension; chronic heart failure IIA, functional class III, stage C, reduced systolic left ventricular function; a two-chamber pacemaker due to complete AV blockade; paroxysmal atrial flutter presented to a cardiologist with worsening shortness of breath and weakness one month after a moderate COVID-19 infection. The patient received bisoprolol 5 mg, amiodarone 200 mg, spironolactone 50 mg, perindopril 8 mg, warfarin 5 mg, INR was carefully controlled, at presentation – 3.7. Echocardiography revealed a left ventricular apex thrombus, a decrease in left ventricular ejection fraction (LVEF) from 46 % to 38 %. Aspirin 75 mg/day, torasemide 10 mg/day, dapagliflozin 10 mg/day, and metabolic therapy were added to the treatment. After 1 month, the patient’s condition improved, no thrombus was detected in the left ventricular cavity, LVEF increased to 46 %. Conclusions. This case demonstrates the problem of careful cardiovascular system state monitoring in patients with prosthetic valves during and after COVID-19, since symptoms of heart cavity or valve thrombosis, worsening heart failure can be mistakenly considered as signs of a viral infection or respiratory failure.
- Open Access
- 27 September 2024
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 32 (3) , 10-16
Patients with STEMI after Revascularization: Is There a Relationship Between Coronary Artery Lesion and Renal Function?
The aim. To establish the relationship between coronary bed lesions and glomerular filtration rate (GFR) calculated on the basis of creatinine, cystatin C and urine albumin-creatinine ratio in patients with ST-elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention. Materials and methods. We examined 286 patients with STEMI, aged 39 to 87 years (mean age 62.8 ± 9.8, median age 64, interquartile range 56 to 71 years), 202 (70.6%) were men and 84 (29.4%) were women. All the patients underwent general clinical tests, coronary angiography with subsequent percutaneous coronary intervention, and echocardiography. Results. The most frequent infarct-related coronary artery (CA) was the anterior interventricular branch of the left coronary artery in the proximal and middle segments, and the right coronary artery in the proximal segment. In general, there was no significant difference in the number of affected CAs among the examined patients. The division of patients into groups according to the level of GFR, determined both on the basis of creatinine and cystatin C, did not reveal significant differences in the distribution of infarct-related CAs. At the same time, the number of patients with multivessel lesions significantly increases with decreased GFR. Depending on the level of the urinary albumin-to-creatinine ratio, a significant increase in the number of patients with two- and multivessel lesions of the CAs was noted. Conclusions. Close correlations between multivessel lesions of CAs and gender, age, urinary albumin-to-creatinine ratio, GFR, left and right atrial size, duration of history of hypertension and diabetes mellitus, presence of II-III degree atrioventricular block and mortality were established.
- 27 September 2024
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 32 (3) , 10-16
Open AccessPatients with STEMI after Revascularization: Is There a Relationship Between Coronary Artery Lesion and Renal Function?
The aim. To establish the relationship between coronary bed lesions and glomerular filtration rate (GFR) calculated on the basis of creatinine, cystatin C and urine albumin-creatinine ratio in patients with ST-elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention. Materials and methods. We examined 286 patients with STEMI, aged 39 to 87 years (mean age 62.8 ± 9.8, median age 64, interquartile range 56 to 71 years), 202 (70.6%) were men and 84 (29.4%) were women. All the patients underwent general clinical tests, coronary angiography with subsequent percutaneous coronary intervention, and echocardiography. Results. The most frequent infarct-related coronary artery (CA) was the anterior interventricular branch of the left coronary artery in the proximal and middle segments, and the right coronary artery in the proximal segment. In general, there was no significant difference in the number of affected CAs among the examined patients. The division of patients into groups according to the level of GFR, determined both on the basis of creatinine and cystatin C, did not reveal significant differences in the distribution of infarct-related CAs. At the same time, the number of patients with multivessel lesions significantly increases with decreased GFR. Depending on the level of the urinary albumin-to-creatinine ratio, a significant increase in the number of patients with two- and multivessel lesions of the CAs was noted. Conclusions. Close correlations between multivessel lesions of CAs and gender, age, urinary albumin-to-creatinine ratio, GFR, left and right atrial size, duration of history of hypertension and diabetes mellitus, presence of II-III degree atrioventricular block and mortality were established.
- Open Access
- 30 June 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (3) , 27-35
Зв’язок співвідношення альбуміну та креатиніну сечі з різними статево-віковими і клінічними характеристиками в пацієнтів з інфарктом міокарда з елевацією сегмента ST
The work method revealed the clinical course of STEMI depending on the functional state of the kidneys and ACR in the urine. Included were 286 patients with acute coronary syndromes, average age 62.8±9.8 years, after revascularization. Among the examined were 202 (70.6%) men and 84 (29.4%) women. It was established that 158 places were classified as ACR 30 mg/mmol. Gender characteristics show that women were significantly more likely to belong to the group of ACR >30 mg/mmol, the distribution into different age gradations according to WHO (2015) showed that at the age of 25–44 all patients belonged to group 1 (ACR >3 mg/mmol ) and group 2 (ACR 3–30 mg/mmol). Among cases aged 75–89, there were significantly more persons with ACR >30 mg/mmol, p1–3=0.003; p2–3=0.01 the value of GFR calculated from the level of cystatin C in plasma according to the CKD-EPI formula Cystatin C shows significantly lower GFR in various categories of ACR based on GFR calculated on the basis of creatinine. With a decrease in GFR, the number of deficiencies that had gradations of ACR 3–30 and ACR >30 significantly increases. The clinical course of STEMI in the treatment of ACR over 30 is characterized by a longer history of hypertension and diabetes, a greater number of patients with diabetes, hereditary history of cardiovascular diseases, diagnosis of atrial fibrillation.
- 30 June 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (3) , 27-35
Open AccessЗв’язок співвідношення альбуміну та креатиніну сечі з різними статево-віковими і клінічними характеристиками в пацієнтів з інфарктом міокарда з елевацією сегмента ST
The work method revealed the clinical course of STEMI depending on the functional state of the kidneys and ACR in the urine. Included were 286 patients with acute coronary syndromes, average age 62.8±9.8 years, after revascularization. Among the examined were 202 (70.6%) men and 84 (29.4%) women. It was established that 158 places were classified as ACR 30 mg/mmol. Gender characteristics show that women were significantly more likely to belong to the group of ACR >30 mg/mmol, the distribution into different age gradations according to WHO (2015) showed that at the age of 25–44 all patients belonged to group 1 (ACR >3 mg/mmol ) and group 2 (ACR 3–30 mg/mmol). Among cases aged 75–89, there were significantly more persons with ACR >30 mg/mmol, p1–3=0.003; p2–3=0.01 the value of GFR calculated from the level of cystatin C in plasma according to the CKD-EPI formula Cystatin C shows significantly lower GFR in various categories of ACR based on GFR calculated on the basis of creatinine. With a decrease in GFR, the number of deficiencies that had gradations of ACR 3–30 and ACR >30 significantly increases. The clinical course of STEMI in the treatment of ACR over 30 is characterized by a longer history of hypertension and diabetes, a greater number of patients with diabetes, hereditary history of cardiovascular diseases, diagnosis of atrial fibrillation.
- 27 June 2024
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 32 (2) , 38-44
Left Ventricular Remodeling after Percutaneous Coronary Intervention in Acute Myocardial Infarction Complicated by Acute Heart Failure
The aim. To establish the relationship between structural-functional and laboratory parameters in patients with myocardial infarction (MI) and heart failure (HF) undergoing percutaneous coronary intervention (PCI). Materials and methods. We examined 308 MI patients who were divided into 3 groups: 161 patients without signs of acute heart failure (AHF) (group I), 99 with Killip class II-III AHF (group II) and 48 with Killip class IV (cardiogenic shock) (group III). All the patients underwent general clinical examinations: complete blood count, lipid profile, creati-nine, quantitative determination of troponin I, D-dimer, creatine kinase-MB, electrocardiography, coronary angiography with PCI, focused cardiac ultrasound and standard echocardiography over 3-5 days. Results. According to the focused cardiac ultrasound, the majority of MI patients with signs of AHF had preserved left ventricle function, and only 8.2% of patients had left ventricle ejection fraction (LVEF) ˂40%. The most significant structural and functional changes were observed in group II. After PCI, a significant increase in left ventricle contractility was found in all groups, but in the group II, the increase in LVEF was more pronounced. The severity of HF manifestations increased depending on the severity of diastolic dysfunction. Many correlations were established: an inverse relationship between LVEF and the presence of HF, the number ofaffected vessels, proximal left anterior descending artery lesions, low-density lipoprotein cholesterol, and atrium fibrilla-tion; a direct relationship between LVEF and hemoglobin levels and glomerular filtration rate. Conclusions. The vast majority of patients with MI and signs of AHF had preserved left ventricle contractile function. High-grade HF manifestations increase depending on the severity of diastolic dysfunction. Myocardial revascularization in MI pa-tients significantly improves functional and volumetric parameters of myocardial function. Numerous correlations between structural-functional and laboratory parameters in patients with MI and HF who underwent PCI have been established.
- 27 June 2024
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 32 (2) , 38-44
Left Ventricular Remodeling after Percutaneous Coronary Intervention in Acute Myocardial Infarction Complicated by Acute Heart Failure
The aim. To establish the relationship between structural-functional and laboratory parameters in patients with myocardial infarction (MI) and heart failure (HF) undergoing percutaneous coronary intervention (PCI). Materials and methods. We examined 308 MI patients who were divided into 3 groups: 161 patients without signs of acute heart failure (AHF) (group I), 99 with Killip class II-III AHF (group II) and 48 with Killip class IV (cardiogenic shock) (group III). All the patients underwent general clinical examinations: complete blood count, lipid profile, creati-nine, quantitative determination of troponin I, D-dimer, creatine kinase-MB, electrocardiography, coronary angiography with PCI, focused cardiac ultrasound and standard echocardiography over 3-5 days. Results. According to the focused cardiac ultrasound, the majority of MI patients with signs of AHF had preserved left ventricle function, and only 8.2% of patients had left ventricle ejection fraction (LVEF) ˂40%. The most significant structural and functional changes were observed in group II. After PCI, a significant increase in left ventricle contractility was found in all groups, but in the group II, the increase in LVEF was more pronounced. The severity of HF manifestations increased depending on the severity of diastolic dysfunction. Many correlations were established: an inverse relationship between LVEF and the presence of HF, the number ofaffected vessels, proximal left anterior descending artery lesions, low-density lipoprotein cholesterol, and atrium fibrilla-tion; a direct relationship between LVEF and hemoglobin levels and glomerular filtration rate. Conclusions. The vast majority of patients with MI and signs of AHF had preserved left ventricle contractile function. High-grade HF manifestations increase depending on the severity of diastolic dysfunction. Myocardial revascularization in MI pa-tients significantly improves functional and volumetric parameters of myocardial function. Numerous correlations between structural-functional and laboratory parameters in patients with MI and HF who underwent PCI have been established.
- Open Access
- 26 June 2023
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 31 (2) , 9-15
Prediction of the Development of Acute Heart Failure of High Grades in Patients with Myocardial Infarction and Percutaneous Coronary Intervention
The aim of the study was to determine the risk factors for the occurrence of acute heart failure (AHF) of high degrees (Killip classes III and IV) among patients with myocardial infarction (MI). Materials and methods. We examined 308 MI patients who were treated at the specialized cardiology department. The mean age of the subjects was 62.9±0.6 years. There were 161 (52.3%) patients with MI without signs of heart failure (HF) (Killip class I), 44 (14.3%) with MI combined with class II AHF, 55 (17.8%) with MI and class III AHF, and 48 (15.6%) with MI and Killip class IV AHF. In addition to the general clinical examination, all the patients underwent additional laboratory examination (quantitative determination of troponin I, D-dimer, creatine kinase-MB, C-reactive protein, N-terminal prohormone of brain natriuretic peptide [NT-proBNP]), echocardiography and lung ultrasound during hospitalization, as well as coronary angiography. Results. A correlation between the occurrence of class III AHF (pulmonary edema) and class IV AHF (cardiogenic shock) and a number of anamnestic, clinical, functional and laboratory indicators was established. The following predictors of the development of class III AHF among patients with MI were calculated through regression analysis: a decrease in the level of O2 saturation during hospitalization, an increase in blood pressure during hospitalization, localization of the main heart attack-related lesion of the distal part of the right coronary artery, a decrease in the left ventricular ejection fraction. With less significance, predictors of the development of class III AHF were also defined as a decrease in the level of hemoglobin, the duration of hypertension in the history, the degree of hypertension, the history of any form of atrial fibrillation. Conclusions. A decrease in diastolic blood pressure irrespective of medical support and an increase in the level of NT-proBNP were established as predictors of the development of Killip class IV AHF. Further studies to predict the occurrence of HF and long-term consequences after MI with high-grade HF are promising and can provide an opportunity to optimize the treatment of patients by preventing severe complications.
- 26 June 2023
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 31 (2) , 9-15
Open AccessPrediction of the Development of Acute Heart Failure of High Grades in Patients with Myocardial Infarction and Percutaneous Coronary Intervention
The aim of the study was to determine the risk factors for the occurrence of acute heart failure (AHF) of high degrees (Killip classes III and IV) among patients with myocardial infarction (MI). Materials and methods. We examined 308 MI patients who were treated at the specialized cardiology department. The mean age of the subjects was 62.9±0.6 years. There were 161 (52.3%) patients with MI without signs of heart failure (HF) (Killip class I), 44 (14.3%) with MI combined with class II AHF, 55 (17.8%) with MI and class III AHF, and 48 (15.6%) with MI and Killip class IV AHF. In addition to the general clinical examination, all the patients underwent additional laboratory examination (quantitative determination of troponin I, D-dimer, creatine kinase-MB, C-reactive protein, N-terminal prohormone of brain natriuretic peptide [NT-proBNP]), echocardiography and lung ultrasound during hospitalization, as well as coronary angiography. Results. A correlation between the occurrence of class III AHF (pulmonary edema) and class IV AHF (cardiogenic shock) and a number of anamnestic, clinical, functional and laboratory indicators was established. The following predictors of the development of class III AHF among patients with MI were calculated through regression analysis: a decrease in the level of O2 saturation during hospitalization, an increase in blood pressure during hospitalization, localization of the main heart attack-related lesion of the distal part of the right coronary artery, a decrease in the left ventricular ejection fraction. With less significance, predictors of the development of class III AHF were also defined as a decrease in the level of hemoglobin, the duration of hypertension in the history, the degree of hypertension, the history of any form of atrial fibrillation. Conclusions. A decrease in diastolic blood pressure irrespective of medical support and an increase in the level of NT-proBNP were established as predictors of the development of Killip class IV AHF. Further studies to predict the occurrence of HF and long-term consequences after MI with high-grade HF are promising and can provide an opportunity to optimize the treatment of patients by preventing severe complications.
- 28 June 2021
- Published by Publishing Company VIT-A-POL in Ukrainian Neurological Journal
- No. 1—2,p. 30—37
Structure of cognitive disorders and predictors of their occurrence in patients after cardiac surgery
Objective — to determine the presence and severity of moderate cognitive disorders (CD) in patients before and after cardiac surgery in the early postoperative period Methods and subjects. 56 patients were examined, including 19 (33.9 %) men and 37 (66,1 %) women , mean age 60.86 ± 8.86. Cardiac surgery was performed for ischemic heart disease in 37 (66.1 %) patients, for valvular heart disease — in 19 (33.9 %, p = 0.02). Assessment of cognitive functions was performed before surgery, on the 3rd and 7th day of the postoperative period using the Montreal Cognitive Test. Results. Before surgery, most patients (75.0 %) had mild CRs, 5.4 % had moderate CRs (p <0.01), and 19.6 % had no CRs (p = 0.02). In general, the distribution by the severity of CR in the early postoperative period did not differ from that before surgery, but there were patients with severe CR (3.6 and 1.8 %, respectively, on the 3rd and 7th days, p = 0.05) ...In the structure of CD, on the 3rd day of the postoperative period, there was a significant decrease in visually constructive skills (4.07 versus 3.7; p < 0.001), a deterioration in the ability to consistently calculate (2.66 versus 2.45; p = 0.02), repetition phrases (1.16 versus 1.0; p = 0.02). On the 7th day of the postoperative period, there was a significant decrease in verbal speed (0.48 versus 0.32; p = 0.006) and an improvement in memory (1.79 versus 2.29; p = 0.01). Probable predictors of the onset of cognitive disorders in the early postoperative period are: a history of stroke — r = –0.282; p = 0.04. There was a correlation with the presence of atherosclerotic lesions of the coronary arteries according to coronary angiography (r = –0.259; p = 0.05), surgery performed under cardiopulmonary bypass (r = 0.29; p = 0.03), and a tendency towards statistical significance of correlation with the presence of signs of dyslipidemia according to lipid profile data (r = –0.227; p = 0.09). Conclusions. It was found that 75 % of patients had mild CR before surgery. The distribution according to the severity of CR in the early postoperative period differed from that before surgery by the appearance of patients with severe CR. In the CR structure, on the 3rd day of the postoperative period, a statistically significant decrease in visual‑constructive skills, a deterioration in the ability to consistently calculate and repeat a phrase were observed. On the 7th day, a statistically significant decrease in verbal speed and an improvement in memory were noted. Probable predictors of CR in the early postoperative period are a history of acute cerebrovascular accident, atherosclerotic lesion of the coronary arteries according to coronary angiography, surgery performed under cardiopulmonary bypass, the presence of signs of dyslipidemia according to lipid profile data.
- 28 June 2021
- Published by Publishing Company VIT-A-POL in Ukrainian Neurological Journal
- No. 1—2,p. 30—37
Structure of cognitive disorders and predictors of their occurrence in patients after cardiac surgery
Objective — to determine the presence and severity of moderate cognitive disorders (CD) in patients before and after cardiac surgery in the early postoperative period Methods and subjects. 56 patients were examined, including 19 (33.9 %) men and 37 (66,1 %) women , mean age 60.86 ± 8.86. Cardiac surgery was performed for ischemic heart disease in 37 (66.1 %) patients, for valvular heart disease — in 19 (33.9 %, p = 0.02). Assessment of cognitive functions was performed before surgery, on the 3rd and 7th day of the postoperative period using the Montreal Cognitive Test. Results. Before surgery, most patients (75.0 %) had mild CRs, 5.4 % had moderate CRs (p <0.01), and 19.6 % had no CRs (p = 0.02). In general, the distribution by the severity of CR in the early postoperative period did not differ from that before surgery, but there were patients with severe CR (3.6 and 1.8 %, respectively, on the 3rd and 7th days, p = 0.05) ...In the structure of CD, on the 3rd day of the postoperative period, there was a significant decrease in visually constructive skills (4.07 versus 3.7; p < 0.001), a deterioration in the ability to consistently calculate (2.66 versus 2.45; p = 0.02), repetition phrases (1.16 versus 1.0; p = 0.02). On the 7th day of the postoperative period, there was a significant decrease in verbal speed (0.48 versus 0.32; p = 0.006) and an improvement in memory (1.79 versus 2.29; p = 0.01). Probable predictors of the onset of cognitive disorders in the early postoperative period are: a history of stroke — r = –0.282; p = 0.04. There was a correlation with the presence of atherosclerotic lesions of the coronary arteries according to coronary angiography (r = –0.259; p = 0.05), surgery performed under cardiopulmonary bypass (r = 0.29; p = 0.03), and a tendency towards statistical significance of correlation with the presence of signs of dyslipidemia according to lipid profile data (r = –0.227; p = 0.09). Conclusions. It was found that 75 % of patients had mild CR before surgery. The distribution according to the severity of CR in the early postoperative period differed from that before surgery by the appearance of patients with severe CR. In the CR structure, on the 3rd day of the postoperative period, a statistically significant decrease in visual‑constructive skills, a deterioration in the ability to consistently calculate and repeat a phrase were observed. On the 7th day, a statistically significant decrease in verbal speed and an improvement in memory were noted. Probable predictors of CR in the early postoperative period are a history of acute cerebrovascular accident, atherosclerotic lesion of the coronary arteries according to coronary angiography, surgery performed under cardiopulmonary bypass, the presence of signs of dyslipidemia according to lipid profile data.